Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
7 Hits
Search Condition : Filter (MeSH = Phenylurea Compounds)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
C2C12(RCB0987)
72007
Lenvatinib causes reduced expression of carnitine/organic cation transporter 2 and carnitine deficiency in the skeletal muscle of rats.
Toxicol Lett
2022-8-1
Pubmed
Full text
Human and Animal Cells
HuH-7
43871
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
J Hepatol
2012-9-1
Pubmed
Full text
Human and Animal Cells
Hep G2
,
HuH-7
43852
Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Br J Cancer
2012-6-5
Pubmed
Full text
Human and Animal Cells
43666
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
J Hepatol
2012-6-1
Pubmed
Full text
Human and Animal Cells
KU812(RCB0495)
,
K562
37627
Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Cancer Res
2009-5-1
Pubmed
Full text
Human and Animal Cells
YSCCC(RCB1549)
,
HuH-28(RCB1943)
17624
Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
J Gastroenterol
2011-6-1
Pubmed
Full text
Human and Animal Cells
A549(RCB0098)
10777
Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf.
J Pharmacol Sci
2009-10-1
Pubmed
Full text